Private equity has transformed the home-based care industry. Over the past decade, PE firms have deployed tens of billions of dollars acquiring home health, hospice, personal care, and IDD agencies — and the pace of investment has only accelerated in 2025–2026.
For agency owners considering a sale, understanding what PE buyers actually look for — and what immediately disqualifies a business — is not just interesting context. It is actionable intelligence that can significantly affect your preparation, timing, and ultimate outcome.
This guide is written from the buyer’s perspective: what does a PE firm’s investment committee need to see to approve an acquisition thesis for a home care agency?
Before getting into specific criteria, it helps to understand why private equity is attracted to home care in the first place. PE investors typically underwrite to three core theses:
1. Demographic inevitability. With 11,000 Americans turning 65 daily and a preference for aging in place that spans all demographics, demand for home-based care has structural, multi-decade tailwinds that are essentially recession-proof.
2. Fragmentation creates consolidation opportunity. The U.S. home care industry is dominated by small, independent operators. The top 10 companies controlled less than 15% of total market revenue as of 2024. This fragmentation means PE firms can acquire at moderate multiples, build scale, and eventually sell the larger platform at a meaningful multiple expansion.
3. Reimbursement predictability. Medicare home health and hospice operate under known, federally-set rates. Compared to hospital or specialist physician physician practice M&A, home care revenue is highly predictable.
Given these theses, a PE buyer evaluating your agency is asking a single core question: “Does this business fit the platform we are building, and can we grow it?”
Most institutional PE buyers have a minimum EBITDA threshold. The market in 2026 breaks down roughly as follows:
| EBITDA Level | Realistic PE Buyer Type |
|---|---|
| <$500K | Smaller sponsorless buyers; some PE searches |
| $500K – $1.5M | Lower-middle-market PE, PE-backed platforms as add-ons |
| $1.5M – $5M | Core lower-middle-market PE; most home care platforms |
| $5M+ | Larger PE platforms; institutional firm primary investments |
Agencies below $500K in EBITDA may still receive PE interest — particularly as add-on acquisitions for existing platforms — but they rarely attract competitive interest from multiple buyers.
PE buyers stress-test every business against the question: “What happens if I lose my most important relationship?” They require:
Agencies with significant concentration are not automatically disqualified, but they receive lower valuations and often face earnout provisions tied to the concentration risk.
A business that depends entirely on the founder is a PE firm’s nightmare. They are buying a going concern — not a personal services business. The minimum they need to see:
If you are the only person who knows how to run the business, the business is not saleable to PE at a premium multiple.
PE firms with existing home care platforms are registered Medicare and Medicaid providers. Acquiring an agency with compliance problems can contaminate their entire portfolio. They screen aggressively for:
Minor historical issues can sometimes be addressed with an indemnification structure. Active investigations or ongoing regulatory exposure will disqualify most transactions.
Three years of clean, accountant-prepared financial statements — ideally reviewed or audited — are the minimum threshold for any institutional buyer. Many PE firms require:
Agencies with cash-based or informal “shoebox” financials rarely attract PE interest, and when they do, they receive deep valuation discounts.
Beyond the must-haves above, these attributes push acquisitions from “approved” to “aggressively priced”:
A business growing at 15%+ per year gets a different underwriting treatment than a flat business, even with the same trailing EBITDA. PE firms model forward years — and a growing business compounds their return. They are buying trajectory, not just current earnings.
For home care agencies serving elderly or chronically ill populations, Medicare certification is a premium signal. Medicare revenue is federal, predictable, and demand is growing. Agencies certified for Medicare home health or hospice command meaningfully higher multiples than non-certified operators.
Caregiver turnover is the operational problem that ruins PE returns in home care. Agencies with 70%+ annual retention rates — and documented practices for achieving it — are perceived as lower-risk and more scalable.
An agency that has built a differentiated care delivery model, proprietary training program, or specialized population management capability has an identifiable moat. PE buyers value differentiation because it is hard for competitors to replicate.
Geographic reach reduces single-market risk and signals operational scalability. A two-county operator is more attractive than a single-county operator at the same revenue level.
PE firms strongly prefer sellers who are willing to roll equity into the platform. An owner who rolls 20–30% of their equity signals confidence in the business and alignment with the buyer’s growth thesis. It also reduces the cash required at close — which PE firms appreciate especially in add-on transactions.
Some attributes will cause PE buyers to pass — regardless of price:
Given everything above, the strategic implication for owners is clear: the best time to begin positioning for PE demand is 12–24 months before you want to sell, not 30 days before.
Specific actions that increase PE attractiveness:
Build your management layer. Hire or promote a clinical director and operations manager. Document their roles, responsibilities, and decision-making authority.
Diversify your referral base. Actively cultivate new referral relationships to reduce concentration. Track referral source diversification as a metric.
Invest in your documentation. Clean financial records, compliant HR practices, and documented clinical processes are not just operational good practice — they are directly monetizable in a sale.
Achieve or maintain Medicare certification. If you’re a personal care agency without Medicare certification, explore whether a Medicare home health certification makes business sense for your market.
Address compliance issues now. Anything pending — a cost report, an audit finding, a wage complaint — should be resolved before going to market. Deals die or get repriced because of issues the seller “assumed would resolve themselves.”
The number of PE-backed home care platforms has grown significantly. Key platform types active in 2026:
Each type has different acquisition criteria, offers different multiples, and requires a different pitch. A skilled advisor knows which buyers are most active, what their current portfolio looks like, and where your agency creates the most strategic value.
Talk to us about the PE buyer universe for your specific business →
Hendon Partners is a sell-side M&A advisory firm for home-based care owners. We never represent buyers.
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.
